Mohd Maaruf Abdul Malik

Mohd Maaruf Abdul Malik

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2019 in Veterinary World
Verified
Journal Article
Open access
MMMohd Maaruf Abdul Malik
Mohd Maaruf Abdul Malik
FOFaizah Othman
Faizah Othman
FHFarida Hussan
Farida Hussan
ASAhmad Nazrun Shuid
Ahmad Nazrun Shuid
QSQODRIYAH HAJI MOHD SAAD
QODRIYAH HAJI MOHD SAAD
Background and Aim: Both virgin coconut oil (VCO) and tocotrienol-rich fraction (TRF) are rich in antioxidants and may protect the bone against bone loss induced by ovariectomy and high-fat diet. The study aimed to determine the protective effects of combined therapy of VCO and TRF on osteoporosis in ovariectomized (OVX) rat fed with high-fat diet. Materials and Methods: Thirty-six female Sprague-Dawley rats were divided into six groups: Sham-operated (SHAM), OVX control, OVX and given Premarin at 64.5 μg/kg (OVX+E2), OVX and given VCO at 4.29 ml/kg (OVX+V), OVX and given TRF at 30 mg/kg (OVX+T), and OVX and given a combination of VCO at 4.29 ml/kg and TRF at 30 mg/kg (OVX+VT). Following 24 weeks of treatments, blood and femora samples were taken for analyses. Results: There were no significant differences in serum osteocalcin levels between the groups (p>0.05), while serum C-terminal telopeptide of Type I collagen levels of the OVX+VT group were significantly lower than the other groups (p<0.05). The dynamic bone histomorphometry analysis of the femur showed that the double-labeled surface/bone surface (dLS/BS), mineral apposition rate, and bone formation rate/BS of the OVX+E2, OVX+T, and OVX+VT groups were significantly higher than the rest of the groups (p<0.05). Conclusion: A combination of VCO and TRF has the potential as a therapeutic agent to restore bone loss induced by ovariectomy and high-fat diet.

Verified
Journal Article
Open access
PDF file
MMMohd Maaruf Abdul Malik
Mohd Maaruf Abdul Malik
ASAhmad Nazrun Shuid
Ahmad Nazrun Shuid
NRNurul Raudzah Adib RAUDZAH ADIB Ridzuan
Nurul Raudzah Adib RAUDZAH ADIB Ridzuan
INIsa Naina-Mohamed
Isa Naina-Mohamed
ERElvy Suhana Mohd Ramli
Elvy Suhana Mohd Ramli
RRRohanizah Abdul Rahim
Rohanizah Abdul Rahim
The genus Acmella has received growing attention for its pharmacological properties, including its potential applications in musculoskeletal disorders (MSDs). Plants in this genus, such as Spilanthes acmella, Blainvillea acmella, Acmella uliginosa, and Acmella oleracea contain various bioactive compounds which have demonstrated anti-inflammatory, analgesic, and anti-arthritic properties. This systematic review evaluates the clinical and preclinical evidence supporting the use of plants from Acmella genus for the treatment of MSD, such as arthritis, osteoporosis, muscle injuries, joint inflammation, and other related pathologies. The methodology used in this study involved a systematic literature review, following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines, along with synthesis analysis and quality appraisal. The articles were retrieved from Scopus, Google Scholar, and PubMed databases. Eleven articles were further analyzed to determine the therapeutic potential of Acmella genus plants for musculoskeletal disorders. The plants included were Spilanthes acmella, Blainvillea acmella, Acmella uliginosa, and Acmella olerecia. The musculoskeletal disorders investigated were osteoporosis, osteoarthritis, and myopathies. The extracts from these plants were shown to decrease inflammation, enhance joint health, relieve pain, and stimulate osteogenic activity. These effects may be attributed to several active compounds found in these plants. The available evidence suggests that Spilanthes acmella and Blainvillea acmella have the potential to treat osteoporosis. Acmella oleracea and Acmella uliginosa have the potential to be used for the treatment of osteoarthritis, while Spilanthes acmella is used to treat myopathies. Further research is needed to establish the efficacy, optimal dosing, and safety of these plants.

4 June 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MMMohd Maaruf Abdul Malik
Mohd Maaruf Abdul Malik
ASAhmad Nazrun Shuid
Ahmad Nazrun Shuid
NRNurul Raudzah Adib RAUDZAH ADIB Ridzuan
Nurul Raudzah Adib RAUDZAH ADIB Ridzuan
INIsa Naina-Mohamed
Isa Naina-Mohamed
ERElvy Suhana Mohd Ramli
Elvy Suhana Mohd Ramli
RRRohanizah Abdul Rahim
Rohanizah Abdul Rahim
Background: The genus Acmella has received growing attention for its pharmacological properties, including its potential applications in musculoskeletal disorders (MSD). Plants in this genus such as Spilanthes acmella, Blainvillea acmella, Acmella uliginosa and Acmella oleracea contain various bioactive compounds which have demonstrated anti-inflammatory, analgesic, and anti-arthritic properties. This systematic review evaluates the clinical and preclinical evidence supporting the use of plants from Acmella genus for treatment of MSD such as arthritis, osteoporosis, muscle injuries, joint inflammation, and other related pathologies. Methods: The methodology used in this study involved a systematic literature review, following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines, along with synthesis analysis and quality appraisal. The articles were retrieved from Scopus, Google Scholar and PubMed databases. Results: Eleven articles were further analysed to determine the therapeutic potential of Acmella genus plants for musculosketelal disorders. The plants included were Spilanthes acmella, Blainvillea acmella, Acmella uliginosa, and Acmella olerecia. The musculoskeletal disorders investigated were osteoporosis, osteoarthritis and myopathies. The extracts from these plants were shown to decrease inflammation, enhance joint health, relieve pain, and stimulate osteogenic activity. These effects may be contributed with several active compounds found in these plants. Conclusions: The available evidence suggests that Spilanthes acmella and Blainvillea acmella have potential to treat osteoporosis. Acmella oleracea and Acmella uliginosa have potential to be used for treatment of osteoarthritis while Spilanthes acmella in treating myopathies. Further research is needed to establish efficacy, optimal dosing, and safety of these plants.

22 August 2025 in Jurnal Teknologi (Sciences & Engineering)
Verified
Journal Article
Open access
PDF file
MMMohd Maaruf Abdul Malik
Mohd Maaruf Abdul Malik
GKGoot Heah Khor
Goot Heah Khor
‘A‘aTiqah Azam
‘aTiqah Azam
NRNurul Raudzah Adib Ridzuan
Nurul Raudzah Adib Ridzuan
ERElvy Suhana Mohd Ramli
Elvy Suhana Mohd Ramli
ASAhmad Nazrun Shuid
Ahmad Nazrun Shuid
A metabolic bone disorder known as osteoporosis is represented by low mineral bone mass and strength. Blainvillea acmella (BA), a herbal plant with antioxidant properties have exhibited anti-osteoporosis effects. The present study set out to discover the osteoprotective effects of BA on bone mechanical properties of the ovariectomized rat model of osteoporosis. Twenty-four Sprague-Dawley female rats were designated into four groups (n=6 per group), namely, (SHAM) sham-operated, (OVX) ovariectomized control, (OVX+E) ovariectomized and supplemented with Premarin 64.5 µg/kg and (OVX+BA) ovariectomized and supplemented with 100 mg/kg of BA ethanolic leaves extract. All rats were euthanized after 12 weeks and the right femurs were tested in three-point bending using Instron Universal Test Machine (Shimadzu AG-X 500N). The bone mechanical properties were evaluated in two parts: extrinsic factors (load, displacement and stiffness) as well as intrinsic factors (stress, strain and Young modulus). The maximum stress and Young modulus of OVX+E and OVX+BA groups indicated considerably higher levels compared to SHAM and OVX groups (p<0.05). No significant differences were found in bone strength between OVX+E and OVX+BA groups. In conclusion, BA leaves extract was comparable to Premarin in maintaining optimal bone strength of the ovariectomized rat model of osteoporosis. Therefore, BA potential in treatment of osteoporosis warrants further investigation.

22 May 2020 in Jurnal Teknologi (Sciences & Engineering)
Verified
Journal Article
Closed access
PDF file
MMMohd Maaruf Abdul Malik
Mohd Maaruf Abdul Malik
DGDina Fariha Che Ab Ghani
Dina Fariha Che Ab Ghani
AUA'ISyah Nabila Uzaimi
A'ISyah Nabila Uzaimi
ASAhmad Nazrun Shuid
Ahmad Nazrun Shuid
Osteoporosis is a metabolic disease characterized by low bone mineral density. Both virgin coconut oil (VCO) and tocotrienol-rich fraction (TRF) are known to have higher antioxidant activity. The study aimed to determine the effect of combined therapy of VCO and TRF on biomechanical bone strength parameters of the ovariectomised rat model fed with high fat diet and heated palm oil. Thirty-six female Sprague-Dawley rats were divided into; Sham-operated (SHAM), ovariectomised control (OVX), ovariectomised and given Premarin 64.5 µg/kg (OVX+P), ovariectomised and given VCO 1.43 ml/kg (OVX+V), ovariectomised and given TRF 30 mg/kg (OVX+T) and ovariectomised and given combined therapy of VCO and TRF (OVX+VT). Following 24 weeks, the rats were sacrificed and the right femora were analyzed for three-point bending test using Shimadzu machine (AG-X 500 N). The parameters were divided into two classes: extrinsic (load, displacement and stiffness) and intrinsic (stress, strain and Young modulus). The statistical tests used were analysis of variance (ANOVA), followed by Tukey’s HSD test. The Young modulus value of OVX+VT group was significantly higher than OVX+V and OVX+T groups (p<0.05). Combined therapy of VCO and TRF have offered better bone protective effects than single dose of VCO or TRF in preventing bone loss of osteoporotic rat model.